DILTIAZEM HYDROCHLORIDE

RPK Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 7, 2023
Approval ID: b7e0adf6-f1ab-432f-a632-0fbbfc519792
Products: 1 registered
Version: 5

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

DILT-XR [Diltiazem Hydrochloride Extended-Release Capsules, USP (Once-a-day dosage), 120 mg, 180 mg and 240 mg

Quick Stats

Total Products1

Labelers2

Label Sections11

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.